Hwa-ping Feng
- Co-authors
- Lila M. GieraschJoan R. ButtertonCraig W. Vander KooiMaurizio PellecchiaErik R. P. ZuiderwegShawn Y. StevensDiana MontgomeryJohn A. Wagner
- Topics
- Hepatitis C virus research (17 papers)HIV/AIDS drug development and treatment (13 papers)Antibiotics Pharmacokinetics and Efficacy (9 papers)
- Partner nations
- United StatesNetherlandsJapan
In The Last Decade
Hwa-ping Feng
38 papers receiving 565 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 245
- Hepatology 181
- Epidemiology 163
- Infectious Diseases 117
- Materials Chemistry 90
Countries citing papers authored by Hwa-ping Feng
This map shows the geographic impact of Hwa-ping Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwa-ping Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwa-ping Feng more than expected).
Fields of papers citing papers by Hwa-ping Feng
This network shows the impact of papers produced by Hwa-ping Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwa-ping Feng. The network helps show where Hwa-ping Feng may publish in the future.
Co-authorship network of co-authors of Hwa-ping Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Hwa-ping Feng. A scholar is included among the top collaborators of Hwa-ping Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hwa-ping Feng. Hwa-ping Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 7 | |
| 7 | 10 | |
| 8 | 11 | |
| 9 | 14 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 7 | |
| 13 | 13 | |
| 14 | 6 | |
| 15 | 12 | |
| 16 | 22 | |
| 17 | 58 | |
| 18 | 78 | |
| 19 | 164 | |
| 20 | 16 |
About Hwa-ping Feng
Hwa-ping Feng is a scholar working on Hepatology, Molecular Medicine and Infectious Diseases, having authored 38 papers that have together received 573 indexed citations. Recurring topics across this work include Hepatitis C virus research (17 papers), HIV/AIDS drug development and treatment (13 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). The work is most often cited by research in Hepatology (181 citations), Molecular Medicine (53 citations) and Applied Microbiology and Biotechnology (20 citations). Hwa-ping Feng has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Lila M. Gierasch, Joan R. Butterton, Craig W. Vander Kooi, Maurizio Pellecchia, Erik R. P. Zuiderweg, Shawn Y. Stevens, Diana Montgomery, John A. Wagner, Ellen G. J. Hulskotte and Edward O’Mara. Their work appears in journals such as Hepatology, Biochemistry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.